DaVita Inc. (NYSE:DVA) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its position in shares of DaVita Inc. (NYSE:DVA) by 4.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,590 shares of the company’s stock after selling 455 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in DaVita were worth $1,434,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in DVA. SBI Securities Co. Ltd. acquired a new position in DaVita during the fourth quarter worth about $41,000. Quarry LP purchased a new position in shares of DaVita during the 3rd quarter worth approximately $60,000. Venturi Wealth Management LLC raised its position in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the last quarter. Versant Capital Management Inc grew its holdings in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares during the last quarter. Finally, Blue Trust Inc. increased its position in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com lowered shares of DaVita from a “buy” rating to a “hold” rating in a report on Friday, March 21st. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. Finally, Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, DaVita currently has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Price Performance

DVA opened at $150.60 on Wednesday. DaVita Inc. has a 1 year low of $125.64 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The company’s 50 day simple moving average is $158.18 and its 200 day simple moving average is $157.57. The stock has a market capitalization of $12.05 billion, a PE ratio of 14.02, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, sell-side analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.